Hyperpolarized 129-Xenon gas
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Bastiaan Driehuys
Overview
Hyperpolarized 129-Xenon gas is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Hyperpolarized 129-Xenon gas clinical trials
Explore related
Medical disclaimer. This page summarizes research about Hyperpolarized 129-Xenon gas for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.